Roche Official: Outcomes-Based Pricing Could Spur Precision Dosing

By Beth Wang / August 15, 2019 at 2:30 PM

Experts say that a cultural change in industry is needed to get drug makers to focus more on precision dosing for drugs, and that both FDA and payers could help push industry in that direction.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.